Epidermolysis Bullosa Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014560584
Market Monitor Global
Oct-2021
Life Sciences
106 Pages

This report contains market size and forecasts of Epidermolysis Bullosa Therapeutics in global, including the following market information:
Global Epidermolysis Bullosa Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Epidermolysis Bullosa Therapeutics Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Epidermolysis Bullosa Therapeutics companies in 2020 (%)
The global Epidermolysis Bullosa Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epidermolysis Bullosa Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epidermolysis Bullosa Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Epidermolysis Bullosa Therapeutics Market Segment Percentages, By Type, 2020 (%)
EB-201
FCX-007
ICX-RHY
INM-750
Others

Global Epidermolysis Bullosa Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Epidermolysis Bullosa Therapeutics Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Epidermolysis Bullosa Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Epidermolysis Bullosa Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epidermolysis Bullosa Therapeutics revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Epidermolysis Bullosa Therapeutics revenues share in global market, 2020 (%)
Key companies Epidermolysis Bullosa Therapeutics sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Epidermolysis Bullosa Therapeutics sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Birken AG
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
ProQR Therapeutics N.V.
RegeneRx Biopharmaceuticals, Inc.
Scioderm, Inc.
Stratatech Corporation
TWi Pharmaceuticals, Inc.
WAVE Life Sciences Ltd.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Epidermolysis Bullosa Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epidermolysis Bullosa Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epidermolysis Bullosa Therapeutics Overall Market Size
2.1 Global Epidermolysis Bullosa Therapeutics Market Size: 2021 VS 2027
2.2 Global Epidermolysis Bullosa Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Epidermolysis Bullosa Therapeutics Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Epidermolysis Bullosa Therapeutics Players in Global Market
3.2 Top Global Epidermolysis Bullosa Therapeutics Companies Ranked by Revenue
3.3 Global Epidermolysis Bullosa Therapeutics Revenue by Companies
3.4 Global Epidermolysis Bullosa Therapeutics Sales by Companies
3.5 Global Epidermolysis Bullosa Therapeutics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Epidermolysis Bullosa Therapeutics Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Epidermolysis Bullosa Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epidermolysis Bullosa Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Epidermolysis Bullosa Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Epidermolysis Bullosa Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Epidermolysis Bullosa Therapeutics Market Size Markets, 2021 & 2027
4.1.2 EB-201
4.1.3 FCX-007
4.1.4 ICX-RHY
4.1.5 INM-750
4.1.6 Others
4.2 By Type - Global Epidermolysis Bullosa Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Epidermolysis Bullosa Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Epidermolysis Bullosa Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Epidermolysis Bullosa Therapeutics Revenue Market Share, 2016-2027
4.3 By Type - Global Epidermolysis Bullosa Therapeutics Sales & Forecasts
4.3.1 By Type - Global Epidermolysis Bullosa Therapeutics Sales, 2016-2021
4.3.2 By Type - Global Epidermolysis Bullosa Therapeutics Sales, 2022-2027
4.3.3 By Type - Global Epidermolysis Bullosa Therapeutics Sales Market Share, 2016-2027
4.4 By Type - Global Epidermolysis Bullosa Therapeutics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Epidermolysis Bullosa Therapeutics Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Epidermolysis Bullosa Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Epidermolysis Bullosa Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Epidermolysis Bullosa Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Epidermolysis Bullosa Therapeutics Revenue Market Share, 2016-2027
5.3 By Application - Global Epidermolysis Bullosa Therapeutics Sales & Forecasts
5.3.1 By Application - Global Epidermolysis Bullosa Therapeutics Sales, 2016-2021
5.3.2 By Application - Global Epidermolysis Bullosa Therapeutics Sales, 2022-2027
5.3.3 By Application - Global Epidermolysis Bullosa Therapeutics Sales Market Share, 2016-2027
5.4 By Application - Global Epidermolysis Bullosa Therapeutics Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Epidermolysis Bullosa Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Epidermolysis Bullosa Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Epidermolysis Bullosa Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Epidermolysis Bullosa Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Epidermolysis Bullosa Therapeutics Revenue Market Share, 2016-2027
6.3 By Region - Global Epidermolysis Bullosa Therapeutics Sales & Forecasts
6.3.1 By Region - Global Epidermolysis Bullosa Therapeutics Sales, 2016-2021
6.3.2 By Region - Global Epidermolysis Bullosa Therapeutics Sales, 2022-2027
6.3.3 By Region - Global Epidermolysis Bullosa Therapeutics Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Epidermolysis Bullosa Therapeutics Revenue, 2016-2027
6.4.2 By Country - North America Epidermolysis Bullosa Therapeutics Sales, 2016-2027
6.4.3 US Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.4.4 Canada Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.4.5 Mexico Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Epidermolysis Bullosa Therapeutics Revenue, 2016-2027
6.5.2 By Country - Europe Epidermolysis Bullosa Therapeutics Sales, 2016-2027
6.5.3 Germany Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.4 France Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.5 U.K. Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.6 Italy Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.7 Russia Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.8 Nordic Countries Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.5.9 Benelux Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Epidermolysis Bullosa Therapeutics Revenue, 2016-2027
6.6.2 By Region - Asia Epidermolysis Bullosa Therapeutics Sales, 2016-2027
6.6.3 China Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.6.4 Japan Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.6.5 South Korea Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.6.6 Southeast Asia Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.6.7 India Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Epidermolysis Bullosa Therapeutics Revenue, 2016-2027
6.7.2 By Country - South America Epidermolysis Bullosa Therapeutics Sales, 2016-2027
6.7.3 Brazil Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.7.4 Argentina Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Epidermolysis Bullosa Therapeutics Sales, 2016-2027
6.8.3 Turkey Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.8.4 Israel Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.8.5 Saudi Arabia Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
6.8.6 UAE Epidermolysis Bullosa Therapeutics Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Birken AG
7.1.1 Birken AG Corporate Summary
7.1.2 Birken AG Business Overview
7.1.3 Birken AG Epidermolysis Bullosa Therapeutics Major Product Offerings
7.1.4 Birken AG Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.1.5 Birken AG Key News
7.2 Fibrocell Science, Inc.
7.2.1 Fibrocell Science, Inc. Corporate Summary
7.2.2 Fibrocell Science, Inc. Business Overview
7.2.3 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.2.4 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.2.5 Fibrocell Science, Inc. Key News
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Corporate Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Plc Key News
7.4 InMed Pharmaceuticals Inc.
7.4.1 InMed Pharmaceuticals Inc. Corporate Summary
7.4.2 InMed Pharmaceuticals Inc. Business Overview
7.4.3 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.4.4 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.4.5 InMed Pharmaceuticals Inc. Key News
7.5 Karus Therapeutics Limited
7.5.1 Karus Therapeutics Limited Corporate Summary
7.5.2 Karus Therapeutics Limited Business Overview
7.5.3 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Major Product Offerings
7.5.4 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.5.5 Karus Therapeutics Limited Key News
7.6 ProQR Therapeutics N.V.
7.6.1 ProQR Therapeutics N.V. Corporate Summary
7.6.2 ProQR Therapeutics N.V. Business Overview
7.6.3 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.6.4 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.6.5 ProQR Therapeutics N.V. Key News
7.7 RegeneRx Biopharmaceuticals, Inc.
7.7.1 RegeneRx Biopharmaceuticals, Inc. Corporate Summary
7.7.2 RegeneRx Biopharmaceuticals, Inc. Business Overview
7.7.3 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.4.4 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.7.5 RegeneRx Biopharmaceuticals, Inc. Key News
7.8 Scioderm, Inc.
7.8.1 Scioderm, Inc. Corporate Summary
7.8.2 Scioderm, Inc. Business Overview
7.8.3 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.8.4 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.8.5 Scioderm, Inc. Key News
7.9 Stratatech Corporation
7.9.1 Stratatech Corporation Corporate Summary
7.9.2 Stratatech Corporation Business Overview
7.9.3 Stratatech Corporation Epidermolysis Bullosa Therapeutics Major Product Offerings
7.9.4 Stratatech Corporation Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.9.5 Stratatech Corporation Key News
7.10 TWi Pharmaceuticals, Inc.
7.10.1 TWi Pharmaceuticals, Inc. Corporate Summary
7.10.2 TWi Pharmaceuticals, Inc. Business Overview
7.10.3 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.10.4 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.10.5 TWi Pharmaceuticals, Inc. Key News
7.11 WAVE Life Sciences Ltd.
7.11.1 WAVE Life Sciences Ltd. Corporate Summary
7.11.2 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Business Overview
7.11.3 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Major Product Offerings
7.11.4 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Sales and Revenue in Global (2016-2021)
7.11.5 WAVE Life Sciences Ltd. Key News
8 Global Epidermolysis Bullosa Therapeutics Production Capacity, Analysis
8.1 Global Epidermolysis Bullosa Therapeutics Production Capacity, 2016-2027
8.2 Epidermolysis Bullosa Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Epidermolysis Bullosa Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Epidermolysis Bullosa Therapeutics Supply Chain Analysis
10.1 Epidermolysis Bullosa Therapeutics Industry Value Chain
10.2 Epidermolysis Bullosa Therapeutics Upstream Market
10.3 Epidermolysis Bullosa Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Epidermolysis Bullosa Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Epidermolysis Bullosa Therapeutics in Global Market
Table 2. Top Epidermolysis Bullosa Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Epidermolysis Bullosa Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Epidermolysis Bullosa Therapeutics Revenue Share by Companies, 2016-2021
Table 5. Global Epidermolysis Bullosa Therapeutics Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Epidermolysis Bullosa Therapeutics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Epidermolysis Bullosa Therapeutics Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Epidermolysis Bullosa Therapeutics Product Type
Table 9. List of Global Tier 1 Epidermolysis Bullosa Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epidermolysis Bullosa Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Birken AG
Fibrocell Science, Inc.
GlaxoSmithKline Plc
InMed Pharmaceuticals Inc.
Karus Therapeutics Limited
ProQR Therapeutics N.V.
RegeneRx Biopharmaceuticals, Inc.
Scioderm, Inc.
Stratatech Corporation
TWi Pharmaceuticals, Inc.
WAVE Life Sciences Ltd.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE